StockDrifts LogoStockDrifts

Orient Bio 002630

Company
오리엔트바이오Orient Bio
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-05-22

Orient Bio (002630) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Orient Bio is dated 2025-12-03; the most recent is 2026-05-22. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-05-22SELL주식병합
오리엔트
Orient
--14.2M₩966-3.1%₩13.7B ($9.5M)
2026-05-22SELL주식병합
장재진
Jaejin Jang
CEO-447.9K₩966-3.1%₩433M ($300K)
2026-05-22SELL주식병합
최숙종
Sookjong Choi
vice president-1.6M₩966-3.1%₩1.6B ($1.1M)
2025-12-03BUY장외매수
오리엔트
Orient
-14.9K₩627+7.5%₩9M ($6K)

Frequently asked questions

Who has been buying Orient Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in Orient Bio (002630), most recently on 2026-05-22. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Orient Bio have?
Orient Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-12-03 to 2026-05-22.
Where does StockDrifts get Orient Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Orient Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.